High Content Imaging Market

High Content Imaging Market Research,2031

High Content Imaging Market to surpass USD 847.54 million by 2031 from USD 847.54 million in 2021 at a CAGR of 11.4% throughout the forecast period 2021-31

High content screening, also known as cellomics, is an image-based screening technique that measures physical and biochemical properties in cells and organisms. To obtain quantitative data from cell populations, it employs a set of analytical procedures such as multi-parameter image processing, automated microscopy, fluorescence imaging, and other visualisation processes. The image capture programme, its evaluation, and data storage are all part of the high content screening. In high content screening, cells are first produced with the substance and then their arrangements and molecular components are examined after a period of time. High-content imaging can be used to analyse whole cells or specific components of cells while simultaneously collecting data on a variety of factors.

Market Highlights

Global High Content Imaging market is expected to project a notable CAGR of 11.4% in 2031.

Global High Content Imaging to surpass USD 1679.24 million by 2031 from USD 847.54 million in 2021 at a CAGR of 11.4% in the coming years, i.e., 2021-31. Increasing advancements in informatics solutions and imaging instruments, as well as the market's increasing need for cost containment in pharmaceutical research and development, are expected to drive demand. Furthermore, rising levels of government investment in the development of the healthcare sector, an increase in the number of patients suffering from chronic diseases requiring intensive treatment, and an increase in the need for determining and studying toxicity levels in the early stages of drug discovery are some of the major factors that will likely augment the growth of the high content screening market.

Figure - Market Analysis of Global High Content Imaging Market

Global High Content Imaging: Segments

Instruments segment to grow with the highest CAGR during 2021-31

Global High Content Imaging market is classified on the basis of Type into Instruments, Consumables, Software, Services and Accessories. The instruments market accounted for the largest share of the high content screening market, owing to advances in instrumentation and automation techniques, as well as the high prices of high content screening instruments. This market's expansion can be attributed to technological advancements in image acquisition, data analysis, and storage capabilities, as well as the need to obtain information on changes in cell morphology via high-quality images.

Primary Screening and Secondary Screening segment to grow with the highest CAGR during 2021-31

Based on application, global High Content Imaging Market is fragmented into Toxicity Studies, Compound Profiling, Target Identification and Validation, Primary Screening and Secondary Screening and Others. During the forecast period, the primary and secondary screening application segment is expected to grow at the fastest CAGR. The rapid growth can be attributed primarily to the widespread use of high content imaging for secondary screening. The presence of a large number of potential drug candidates for target-specific delivery can also be attributed to growth in the primary and secondary screening segments.

Figure - Market Analysis of Global High Content Imaging Market

Market Dynamics

Drivers

Rising need for drug development and technological advancements

The global high content screening market is expected to grow lucratively as a result of the increasing need for the development of new drug molecules as a result of the presence of obsolete drug therapies with lower potency. Technological advancements such as the use of multicoloured fluorescence-based reagents, polarisation techniques, automated imaging technology, and flow cytometry are expected to fuel market growth even further. Furthermore, benefits associated with these innovations, such as use in gene identification and neonatal development studies, as well as improved drug penetrability, are expected to provide growth potential to the market over the forecast period.

Increased funding for cellular research and contact research organisatiolns

The need for cost containment in pharma R&D, growth in funding for cellular research, and technological advancements in High Content Imaging solutions are expected to drive the high content screening market during the forecast period. Increasing the number of contract research organization providing high content imaging services, as well as the increasing number of applications of high content screening in personalised medicine is expected to contribute to the growth of the high content screening market in the forecasted period.

Restraint

High cost associated with the market

The high cost of High Content Imaging instruments, as well as a scarcity of knowledgeable and skilled personnel for operating high-content screening instruments, is expected to limit market growth to some extent.

Global High Content Imaging: Key Players

• Danaher Corp.

Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis

• GE Healthcare
• Instrument Systems
• Perkinelmer Inc.
• Thermo Fisher Scientific Inc.
• Becton Dickinson
• Biotek Instruments Inc.
• Bio-Rad Laboratories Inc.
• Yokogawa Electric Corporation
• Other Prominent Players

Global High Content Imaging: Regions

Global High Content Imaging market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. High R&D spending, the presence of major pharmaceutical market players, and increased government support are some of the factors contributing to North America's large market share. Increased drug discovery research, government initiatives, and a growing focus of multinational corporations on emerging markets are also factors driving market.

Global High Content Imaging is further segmented by region into:

• North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States and Canada
• Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
• Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
• Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
• Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA

Global High Content Imaging report also contains analysis on:

High Content Imaging Segments:

• By Type 
  • Instruments
  • Consumables
  • Software
  • Services
  • Accessories
• By Application 
  • Toxicity Studies
  • Compound Profiling
  • Target Identification and Validation
  • Primary Screening and Secondary Screening
  • Others
• High Content Imaging Dynamics
• High Content Imaging Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies Involved in the Market
• Value Chain of the Market
• Market Drivers and Restraints

High Content Imaging Market Report Scope and Segmentation

Frequently Asked Questions (FAQ):